<?xml version='1.0' encoding='utf-8'?>
<document id="31839713"><sentence text="Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy-apoptosis crosstalk pathway."><entity charOffset="0-11" id="DDI-PubMed.31839713.s1.e0" text="Chloroquine" /><entity charOffset="43-54" id="DDI-PubMed.31839713.s1.e1" text="osimertinib" /><pair ddi="false" e1="DDI-PubMed.31839713.s1.e0" e2="DDI-PubMed.31839713.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s1.e0" e2="DDI-PubMed.31839713.s1.e1" /></sentence><sentence text="Background: Triple-negative breast cancer (TNBC) is a breast cancer that tests negative for estrogen receptor (ER), progesterone receptors, and human epidermal growth factor receptors 2 (HER2)"><entity charOffset="92-100" id="DDI-PubMed.31839713.s2.e0" text="estrogen" /><entity charOffset="116-128" id="DDI-PubMed.31839713.s2.e1" text="progesterone" /><pair ddi="false" e1="DDI-PubMed.31839713.s2.e0" e2="DDI-PubMed.31839713.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s2.e0" e2="DDI-PubMed.31839713.s2.e1" /></sentence><sentence text=" It is aggressive and invasive in nature and lacks targeted therapy" /><sentence text=" Purpose: The EGFR is frequently overexpressed in TNBC, and the EGFR-overexpressing TNBC presumably escapes EGFR inhibitor therapy by upregulating autophagy and inhibiting apoptosis" /><sentence text=" Methods: To parse the autophagy-apoptosis crosstalk pathway as a potential targeted therapy in TNBC, the activity of an EGFR inhibitor, osimertinib, alone and in combination with an autophagy inhibitor, chloroquine, was examined in EGFR-overexpressing TNBC cell line, MDA-MB-231"><entity charOffset="137-148" id="DDI-PubMed.31839713.s5.e0" text="osimertinib" /><entity charOffset="204-215" id="DDI-PubMed.31839713.s5.e1" text="chloroquine" /><pair ddi="false" e1="DDI-PubMed.31839713.s5.e0" e2="DDI-PubMed.31839713.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s5.e0" e2="DDI-PubMed.31839713.s5.e1" /></sentence><sentence text=" The nature of interaction between both drugs at various concentrations was determined by calculating combination indexes (CI) using CompuSyn software" /><sentence text=" Temporal changes in the expression of the autophagy marker, LC3B-II, and several apoptosis signaling molecules were measured using Western blot and luminex assay with MAGPIX® after exposure to drugs" /><sentence text=" A synergistic interaction (CI &lt;1) was identified with combinations of 4-6" /><sentence text="5 μM osimertinib with 30-75 μM chloroquine"><entity charOffset="0-16" id="DDI-PubMed.31839713.s9.e0" text="5 μM osimertinib" /><entity charOffset="31-42" id="DDI-PubMed.31839713.s9.e1" text="chloroquine" /><pair ddi="false" e1="DDI-PubMed.31839713.s9.e0" e2="DDI-PubMed.31839713.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s9.e0" e2="DDI-PubMed.31839713.s9.e1" /></sentence><sentence text=" Results: A combination of osimertinib (6 μM) with chloroquine (30 μM) resulted in a 6-fold increase of LC3B-II relative to control compared to 2"><entity charOffset="27-38" id="DDI-PubMed.31839713.s10.e0" text="osimertinib" /><entity charOffset="51-62" id="DDI-PubMed.31839713.s10.e1" text="chloroquine" /><pair ddi="false" e1="DDI-PubMed.31839713.s10.e0" e2="DDI-PubMed.31839713.s10.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s10.e0" e2="DDI-PubMed.31839713.s10.e1" /></sentence><sentence text="5-fold increase for either drug alone" /><sentence text=" The caspase-3 expression increased 2-fold compared to a 0" /><sentence text="5-fold decrease with chloroquine and 1"><entity charOffset="21-32" id="DDI-PubMed.31839713.s13.e0" text="chloroquine" /></sentence><sentence text="5-fold increase with osimertinib"><entity charOffset="21-32" id="DDI-PubMed.31839713.s14.e0" text="osimertinib" /></sentence><sentence text=" Conclusion: Our results indicate that inhibition of the autophagic flux via chloroquine improves the effectiveness of osimertinib in TNBC cancer cells, warranting further investigations of this combination in vivo"><entity charOffset="77-88" id="DDI-PubMed.31839713.s15.e0" text="chloroquine" /><entity charOffset="119-130" id="DDI-PubMed.31839713.s15.e1" text="osimertinib" /><pair ddi="false" e1="DDI-PubMed.31839713.s15.e0" e2="DDI-PubMed.31839713.s15.e0" /><pair ddi="false" e1="DDI-PubMed.31839713.s15.e0" e2="DDI-PubMed.31839713.s15.e1" /></sentence><sentence text="" /></document>